The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008
Abstract
BACKGROUND: Millions of cases of sexually transmitted infections (STIs) occur in the United States each year, resulting in substantial medical costs to the nation. Previous estimates of the total direct cost of STIs are quite dated. We present updated direct medical cost estimates of STIs in the United States. METHODS: We assembled recent (i.e., 2002-2011) cost estimates to determine the lifetime cost per case of 8 major STIs (chlamydia, gonorrhea, hepatitis B virus, human immunodeficiency virus (HIV), human papillomavirus, genital herpes simplex virus type 2, trichomoniasis and syphilis). The total direct cost for each STI was computed as the product of the number of new or newly diagnosed cases in 2008 and the estimated discounted lifetime cost per case. All costs were adjusted to 2010 US dollars. RESULTS: Results indicated that the total lifetime direct medical cost of the 19.7 million cases of STIs that occurred among persons of all ages in 2008 in the United States was $15.6 (range, $11.0-$20.6) billion. Total costs were as follows: chlamydia ($516.7 [$258.3-$775.0] million), gonorrhea ($162.1 [$81.1-$243.2] million), hepatitis B virus ($50.7 [$41.3-$55.6] million), HIV ($12.6 [$9.5-$15.7] billion), human papillomavirus ($1.7 [$0.8-$2.9] billion), herpes simplex virus type 2 ($540.7 [$270.3-$811.0] million), syphilis ($39.3 [$19.6-$58.9] million), and trichomoniasis ($24.0 [$12.0-$36.0] million). Costs associated with HIV infection accounted for more than 81% of the total cost. Among the nonviral STIs, chlamydia was the most costly infection. CONCLUSIONS: Sexually transmitted infections continue to impose a substantial cost burden on the payers of medical care in the United States. The burden of STIs would be even greater in the absence of STI prevention and control efforts.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For females, the cost per STI case ranges from $247 for Human Papilloma Virus (HPV) to $804 for Herpes-Simples Virus (HSV2).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
In the citing paper
“The average cost per case of syphilis is $918 (either gender).”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
In the citing paper
“For males, the cost per case ranges from $39 for Chlamydia to $985 for HSV2.”
From Monetary conversion factors for economic evaluations of substance use disorders (2017) · cites this paper as Owusu-Edusei et al., 2013
Citations
Cites
Gardner, E. M., McLees, M. P., Steiner, J. F., del Rio, C., & Burman, W. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq243 · Cited by 1,893 · cited 1×
“However, this estimate is applicable when considering the best-case scenario of HIV care in the United States, implying that applying their estimate could overestimate the total direct cost of HIV, because not all patients with HIV receive care and not all those who receive care get the best care available.(25,26) Hut…”
BackgroundSexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2008
Satterwhite, C. L., Torrone, E., Meites, E., Dunne, E. F., Mahajan, R., Ocfemia, M. C. B., Su, J., Xu, F., & Weinstock, H. (2013) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318286bb53 · Cited by 1,260
Self-citationSexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3600604 · Cited by 1,258
Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000
Weinstock, H., Berman, S., & Cates, W. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1111/j.1931-2393.2004.tb00002.x · Cited by 1,153
Estimated HIV Incidence in the United States, 2006–2009
Prejean, J., Song, R., Hernandez, A., Ziebell, R., Green, T., Walker, F., Lin, L. S., An, Q., Mermin, J., Lansky, A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017502 · Cited by 1,071 · cited 1×
“For instance, in the past few years, the reported annual incidence of chlamydia, syphilis, and genital warts has increased,(6) although the annual incidence of gonorrhea and HIV infection has been relatively stable.(6,7) In addition, given the rapid changes in health care technology and service delivery, the lifetime…”
BackgroundRisk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Haggerty, C. L., Gottlieb, S. L., Taylor, B. D., Low, N., Xu, F., & Ness, R. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652395 · Cited by 657 · cited 1×
“5% of treated asymptomatic cases in women, with no PID assumed to develop in treated women with symptomatic chlamydia.(15) We assumed epididymitis developed in 1.”
BackgroundThe Estimated Direct Medical Cost of Sexually Transmitted Diseases Among American Youth, 2000
Chesson, H. W., Blandford, J. M., Gift, T. L., Tao, G., & Irwin, K. L. (2004) · Perspectives on Sexual and Reproductive Health · doi:10.1363/3601104 · Cited by 444 · cited 8×
“Screening costs for asymptomatic persons were not included; in our previous estimate, these costs were included as part of the overall burden of chlamydia for persons infected with chlamydia.(1) We used previously published estimates of diagnosis and treatment costs for patients diagnosed in private physician/ health…”
BackgroundMethodResultInfluentialSelf-citationDevelopment and Duration of Human Papillomavirus Lesions, after Initial Infection
Winer, R. L., Kiviat, N. B., Hughes, J. P., Adam, D. E., Lee, S., Kuypers, J. M., & Koutsky, L. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427557 · Cited by 417
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States
Schackman, B. R., Gebo, K. A., Walensky, R. P., Losina, E., Muccio, T., Sax, P. E., Weinstein, M. C., Seage, G. R., Moore, R. D., & Freedberg, K. A. (2006) · Medical Care · doi:10.1097/01.mlr.0000228021.89490.2a · Cited by 410 · cited 5×
“We reviewed 2 recent studies that estimated the direct lifetime cost of HIV infection in the United States (Schackman et al.(23) and Hutchinson et al.”
BackgroundMethodInfluentialHs, M. (1995) · JAMA · doi:10.1001/jama.274.15.1201 · Cited by 323 · cited 1×
“For example, the potential costs of liver transplantation were included in the 3 source studies cited earlier, whereas liver transplantation costs were not reflected in our original estimate.(1,22)”
Background
Cited by
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Papp, J. R., Schachter, J., Gaydos, C. A., & Pol, B. J. V. D. (2014) · PubMed · Cited by 654
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ771 · Cited by 588
Lifetime Economic Burden of Intimate Partner Violence Among U.S. Adults
Peterson, C., Kearns, M. C., McIntosh, W. L., Estefan, L. F., Nicolaidis, C., McCollister, K. E., Gordon, A., & Florence, C. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.049 · Cited by 471
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health
Petrova, M. I., Lievens, E., Malik, S., Imholz, N., & Lebeer, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00081 · Cited by 523
Metadata
- Authors
- Owusu-Edusei, K., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C. B., & Kent, C. K.
- Corresponding author
- Chesson, Harrell W.
- Gift, Thomas L.
- Tao, Guoyu
- Kent, Charlotte K.
- Venue
- Sexually Transmitted Diseases
- Published
- 2013-03
- Volume
- 40
- Issue
- 3
- Pages
- 197-201
- ISSN
- 0148-5717 (ISSN-L)
- OpenAlex
- W2064915358
- Cited by
- 452
- References
- 32
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 9 · 2023: 20 · 2022: 21 · 2021: 37 · 2020: 39 · 2019: 39 · 2018: 45 · 2017: 75 · 2016: 41 · 2015: 46 · 2014: 53 · 2013: 17
- FWCI
- 47.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Sexually Transmitted Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › HIV, TB, and STIs Epidemiology
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Keywords
- sexually transmitted infections, direct medical costs, HIV, chlamydia, gonorrhea, hepatitis B virus, human papillomavirus, herpes simplex virus type 2, syphilis, trichomoniasis, cost burden
- MeSH terms
- Chlamydia Infections, Condylomata Acuminata, Female, Gonorrhea, Hepatitis B, Herpes Genitalis, Humans, Male, Sexually Transmitted Diseases, Syphilis, Trichomonas Infections, United States, HIV Infections, Health Care Costs, Cost of Illness, Models, Economic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008. https://app.cochat.ai/papers/10.1097/olq.0b013e318285c6d2
- The paper
- Owusu-Edusei, K., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C. B., & Kent, C. K. (2013). The Estimated Direct Medical Cost of Selected Sexually Transmitted Infections in the United States, 2008. Sexually Transmitted Diseases. https://doi.org/10.1097/olq.0b013e318285c6d2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.